Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Calyxt Inc (CLXT) USD0.0001

Sell:$4.47 Buy:$4.57 Change: $0.16 (3.45%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$4.47
Buy:$4.57
Change: $0.16 (3.45%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$4.47
Buy:$4.57
Change: $0.16 (3.45%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Calyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.

Contact details

Address:
2800 Mount Ridge Rd
ROSEVILLE
55113-4461
United States
Telephone:
+1 (651) 6832807
Website:
www.calyxt.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CLXT
ISIN:
US13173L1070
Market cap:
$153.31 million
Shares in issue:
33.04 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Yves Ribeill
    Chairman of the Board
  • James Blome
    Chief Executive Officer, Director
  • William Koschak
    Chief Financial Officer
  • Keith Blanks
    Senior Vice President of Sales and Marketing
  • Travis Frey
    Chief Technology Officer
  • Daniel Voytas
    Chief Scientific Officer
  • Vince Restucci
    Vice President of Agronomy Services
  • Debra Frimerman
    General Counsel
  • Bobby Williams
    Director - Gene Editing

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.